In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed ...

金融时报消息，总部位于英国伦敦的 Isomorphic Labs 宣布完成6 亿美元融资。本次由 Thrive Capital 领投，现有投资者谷歌的母公司Alphabet、GV也进行了追加投资。 这笔资金将用于进一步开发其人工智能驱动的药物设计技术，并推动治疗方案进入临床试验阶段。

Isomorphic Labs, the London-based, drug discovery–focused spinout of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants, Eli ...

Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs ...

eSpeaks host Corey Noles sits down with Qualcomm's Craig Tellalian to explore a workplace computing transformation: the rise of AI-ready PCs. Matt Hillary, VP of Security and CISO at Drata, details ...

杰米斯•哈萨比斯(Demis Hassabis)创立了谷歌DeepMind，同时也是药物部门Isomorphic Labs的负责人，他表示，目标是将初始阶段从大约五年缩短到两年 谷歌DeepMind公司的负责人认为，该公司的药物研发部门将把寻找新药的时间缩短一半，这吸引了全球最大制药公司的注意 ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...

What if it’s not "just a game"? In AI, games are more than just fun—they can reconceive what’s possible. Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, knows this firsthand. In 2016, ...